Los Angeles Times reported on two studies in which researchers used synthetic biology and whole-cell biosensors to detect biomarkers of disease. One approach detected elevated glucose in patients' urine and the other signaled early stage liver cancer in mice. NIBIB program director Jessica Tucker, Ph.D., Synthetic Biology for Technology Development Program, NIBIB, commented for the article. Read the full article at www.latimes.com.
Health Terms:
Cancer,
Diabetes,
Diagnostic,
Point of Care